Description: The peptide is used to block Anti-VEGFR2 (pY1054/Y1063) Antibody (#CPA5881) reactivity. Form: Lyophilized powder Gene Symbol: KDR; FLT4 Alternative Names: KDR; FLK1; VEGFR2; Vascular endothelial growth factor receptor 2; VEGFR-2; Fetal liver kinase 1; FLK-1; Kinase insert domain receptor; KDR; Protein-tyrosine kinase receptor flk-1; CD309; FLT4; VEGFR3; Vascular endothelial growth factor receptor 3; VEGFR-3; Fms-like tyrosine kinase 4; FLT-4; Tyrosine-protein kinase receptor FLT4Entrez Gene (Human): 3791; 2324Entrez Gene (Mouse) : 14257Entrez Gene (Rat) : 25589; 114110SwissProt (Human): P35968; P35916SwissProt (Mouse) : P35918; P35917SwissProt (Rat) : O08775; Q91ZT1Purity : >85%Directions for Use : Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours.Quality Control : The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.Storage/Stability : Shipped at 4°C. Store at -20°C for one year.